Gross Margin % is calculated as gross profit divided by its revenue. The Cooper's Gross Profit for the
three
months ended in Jul. 2024 was $663 Mil. The Cooper's Revenue for the
three
months ended in Jul. 2024 was $1,003 Mil. Therefore, The Cooper's Gross Margin % for the quarter that ended in Jul. 2024 was 66.11%.
The historical rank and industry rank for The Cooper's Gross Margin % or its related term are showing as below:
COO'
s Gross Margin % Range Over the Past 10 Years
Min: 59.56 Med: 64.15 Max: 66.92
Current: 66.36
During the past 13 years, the highestGross Margin % of The Cooper was 66.92%. The lowest was 59.56%. And the median was 64.15%.
COO's Gross Margin % is ranked better than 70.83% of 809
companies
in the Medical Devices & Instruments industry
Industry Median: 52.08
vs COO: 66.36
The Cooper had a gross margin of 66.11% for the quarter that ended in Jul. 2024 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for The Cooper was 0.20% per year.
The Cooper Gross Margin % Historical Data
The historical data trend for The Cooper's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of The Cooper's Gross Margin %
For the Medical Instruments & Supplies subindustry, The Cooper's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Cooper's Gross Margin % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's Gross Margin % distribution charts can be found below:
* The bar in red indicates where The Cooper's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
The Cooper (NAS:COO) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
The Cooper had a gross margin of 66.11% for the quarter that ended in Jul. 2024 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
The Cooper Gross Margin % Related Terms
Thank you for viewing the detailed overview of The Cooper's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
CooperCompanies is one of the largest eyecare companies in the us. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the us contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the us, and controls 17% of the us IUD market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
COO has been successfully added to your 